The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

But sometimes life throws us curveballs, like a major health issue. It's no fun to navigate treatment for cancer or other ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Researchers have ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

In a recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98% specificity and 73% sensitivity across all stages.

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...

All Babbo Italian Eatery profits on Feb. 26 benefit pancreatic cancer research. It's part of the annual Baseball for Babbo ...